SCHEMBL8778972

SCHEMBL8778972

O=C1c2cc([N+](=O)[O-])ccc2CCC12CCCC2

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR2A P28223 3/20 0.49
HTR2C P28335 3/20 0.49
HTR2B P41595 3/20 0.49
SIGMAR1 Q99720 3/20 0.49
DRD2 P14416 1/20 0.49
CA1 P00915 2/20 0.45
CA2 P00918 2/20 0.45
CA9 Q16790 2/20 0.45
CA7 P43166 1/20 0.45
MAPT P10636 2/20 0.45
GAA P10253 1/20 0.45
TDP2 O95551 1/20 0.44
CYP3A4 P08684 1/20 0.44
TDP1 Q9NUW8 1/20 0.44
PTPRC P08575 3/20 0.44
S100A4 P26447 2/20 0.44
CAPN9 O14815 1/20 0.41
CASP3 P42574 1/20 0.41
ALDH1A1 P00352 1/20 0.41
MALT1 Q9UDY8 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6841697 0.87 ADRA2A (0.47) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL6840810 0.83 SIGMAR1 (0.51) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL3982285 0.82 CA1 (0.47) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL8914100 0.81 HTR2A (0.49) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL4336912 0.81 CA1 (0.46) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL6836358 0.80 SIGMAR1 (0.58) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL16559365 0.77 MAPT (0.61) CA1CA2CA9CA7MAPT
SCHEMBL8779110 0.75 SIGMAR1 (0.43) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL8779154 0.75 PARP1 (0.46) HTR2AHTR2CHTR2BSIGMAR1DRD2
SCHEMBL22892512 0.75 SIGMAR1 (0.46) HTR2AHTR2CHTR2BSIGMAR1DRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0606661-B1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists HOFFMANN LA ROCHE (CH) 1997-03-12 EP disclosed
US-5385947-A For prevention of nerve damage due to reduction of blood or oxygen supplies HOFFMANN-LA ROCHE INC. (US) 1995-01-31 US disclosed
EP-0606661-A1 Octahydrophenanthrene derivatives and their use as NMDA-Antagonists F. HOFFMANN-LA ROCHE AG (CH) 1994-07-20 EP disclosed